视网类药物对视网类X受体反应通路具有选择性.
J M Lehmann1, L Jong, A Fanjul
1Cancer Center, La Jolla Cancer Research Foundation, La Jolla, CA 92037.
概括
新的视网类药物可以选择性地激活视网类X受体 (RXRs) 类同质体,独立于视网酸受体 (RARs). 这允许独立激活不同的视网体信号通路.
科学领域:
- 分子生物学分子生物学
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 视网类药物是具有多种生物活性的关键治疗剂.
- 视网体信号传递主要由视网酸受体 (RARs) 和视网体X受体 (RXRs) 介导.
- 通常,RARs与RXR作为异构体,用于DNA结合和转录调节.
研究的目的:
- 开发能够选择性向特定视网体受体复合物的新型视网体.
- 调查RXR同位体与RAR-RXR异位体的独立激活潜力.
- 通过剖析视网体信号通路来探索新的治疗策略.
主要方法:
- 一个新系列的视网类药物的合成和特征.
- 在体外测试以评估RXR同位体和RAR-RXR异位体的激活.
- 对受体-连接体相互作用和下游信号效应的分析.
主要成果:
- 确定了一系列新型的视网类药物,可以选择性地激活RXR同位素.
- 这些视网类药物没有显著激活RAR-RXR异构体.
- 在不影响RAR-RXR异构体功能的情况下,实现了RXR同构体活性的独立调节.
结论:
- 这些发现证明了独立激活明显的视网体信号通路的可行性.
- 这种选择性激活为微调基于视网体的疗法提供了一种新方法.
- 专门针对RXR同位体开辟了新型治疗干预的途径,减少了目标外效应.
更多相关视频
06:56A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4
Published on: March 10, 2018
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
相关概念视频
Drug-Receptor Interactions
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Principles of Drug Action
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Dose-Response Relationship: Selectivity and Specificity
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and β2-adrenergic receptors...
Drug-Receptor Interaction: Antagonist
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
